Cincor pharma inc. stock price

Author: gheb

August undefined, 2024

WebThe CinCor Pharma, Inc. stock prediction for 2025 is currently $ 19.40, assuming that CinCor Pharma, Inc. shares will continue growing at the average yearly rate as they did … WebCompany profile page for CinCor Pharma Inc including stock price, company news, press releases, executives, board members, and contact information

How to buy CinCor Pharma stock - (NASDAQ: CINC) stock price …

WebCinCor Pharma Inc is a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. ... Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS; $29.06: $29.20: $10.53 - $43.15: $1.27B: 43.8M: 738K-$2.43: CinCor Pharma ... highest rated well pumps

CinCor Pharma Inc - Company Profile and News

WebWebull offers kinds of CINCOR PHARMA INC stock information, including NASDAQ:CINC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, … WebCincor Pharma Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. WebFeb 23, 2024 · CinCor Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing its lead clinical candidate, CIN-107, for the treatment … highest rated weight loss pills

CINCOR PHARMA, INC. : CINC Stock Quotes and Prices

CinCor Pharma Announces Pricing of Upsized Public Offering

WebSep 14, 2024 · Insiders who bought CinCor Pharma, Inc. (NASDAQ:CINC) in the last 12 months may probably not pay attention to the stock's recent 5.5% drop. Reason being, despite the recent loss, insiders original ... WebJan 9, 2024 · We are investigating the conduct of CinCor's board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for ... how have we becoem slaves to techonolgyWebFeb 23, 2024 · AstraZeneca announced today the successful completion of the acquisition of CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled hypertension as well as chronic kidney disease. The acquisition bolsters AstraZeneca's cardiorenal pipeline by … highest rated weight loss products

"WebCincor Pharma Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... It is based on a 60-month historical regression … " - Cincor pharma inc. stock price

Cincor pharma inc. stock price

WebJan 9, 2024 · Check out our CINC stock analysis, current CINC quote, charts, and historical prices for CinCor Pharma, Inc. - Common Stock stock WebDelisted. Webull offers kinds of CINCOR PHARMA INC stock information, including NASDAQ:CINC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CINC stock news, and many more online research tools to help you make informed decisions. You can practice and explore trading CINC stock ...

Did you know?

WebJan 10, 2024 · CinCor Pharma Inc (CINC) stock is trading at $28.85 as of 12:42 PM on Tuesday, Jan 10, a rise of $0.10, or 0.37% from the previous closing price of $28.74. Volume today is 631,021 compared to average volume of 841,035. The stock has traded between $28.50 and $29.31 so far today. WebDec 6, 2024 · CinCor Pharma sheds 27% as blood pressure candidate fails in mid-stage study Seeking Alpha 11/28/2024 CinCor Pharma Inc. (CINC) Sits And Waits For …

WebApr 2, 2024 · 6 analysts have issued twelve-month price objectives for CinCor Pharma's stock. Their CINC share price forecasts range from $30.00 to $67.00. On average, they … WebCINC Nasdaq Stock Market • NLS real time price • CURRENCY IN USD • Biotechnology & Medical Research. CINCOR PHARMA, INC. CINCOR PHARMA, INC. 29.06 ...

WebAt Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you … WebThe Investor Relations website contains information about CinCor Pharma Inc's business for stockholders, potential investors, and financial analysts.

WebTwo crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.

WebFind the latest stock market trends and activity today. Compare key indexes, including Nasdaq Composite, Nasdaq-100, Dow Jones Industrial & more. highest rated wells fargo fundWebThe CinCor Pharma, Inc. stock prediction for 2025 is currently $ 19.40, assuming that CinCor Pharma, Inc. shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a -33.24% increase in the CINC stock price. highest rated wheeled office school bagWebFeb 21, 2024 · WALTHAM, Mass., Feb. 21, 2024 -- CinCor Pharma, Inc. announced today completion of an End-of-Phase 2 meeting with the U.S. Food and Drug Administration on the anticipated Phase 3 program for... April 8, 2024 highest rated weight loss programWebCinCor Pharma Inc. company facts, information and financial ratios from MarketWatch. ... 12/01 EU edges closer to imposing $60-a-barrel cap on Russian oil prices ... 12/01 Tesla stock ends flat ... how have water features influenced canadaWebAug 15, 2024 · WALTHAM, Mass., Aug. 15, 2024 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate ... how have viruses evolvedWebCompany profile page for CinCor Pharma Inc including stock price, company news, press releases, executives, board members, and contact information highest rated welding schools in texasWebJan 7, 2024 · add_box. BOSTON, Jan. 06, 2024 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate ... how have walruses adapted to the arctic